Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Psyched Wellness' Kevin Feeney says Amanita Muscaria 'more practical' than psilocybin mushrooms

Psyched Wellness' Kevin Feeney says Amanita Muscaria 'more practical' than psilocybin mushrooms

Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) Advisor Kevin Feeney tells Proactive he feels the Amanita Muscaria, which Psyched Wellness is working with, is 'more practical' than psilocybin mushrooms.

Feeney, who recently published his new book focused on the mushroom, entitled, "Fly Agaric: A Compendium of History, Pharmacology, Mythology, and Exploration" says the use of psilocybin requires a therapeutic setting with a therapist, while the Amanita Muscaria can potentially be used as a supplement for patients at home to treat anxiety, insomnia, and more.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK